Cineplex: Consensus Price Target Sees Marginal Lift Post Earnings

Cineplex Inc. (TSX: CGX) reported their first-quarter financial results last week, with the company reporting $41 million in revenue, down 85% year over year. Gross margin came in at 69.6%, 390bps higher than it was a year ago, net income meanwhile was $(90) and earnings per share was $(1.42)

A few analysts changed their 12-month price target on Cineplex after the earnings, with the companies 12-month price target slowly inching up to $13.00 from the $12.64 average last month via a total of seven analysts. National Bank has the highest 12-month price target of $17 while the lowest is a $9 price target.

In BMO’s note, their analyst Tim Casey reiterated his market perform rating and $12 price target on the company. Casey refers to this quarter as “not meaningful,” as the business was still locked down and they are looking forward to the second half of 2021 when they are forecasting things to get better.

Casey writes, “We expect marginal improvements in operating results for Q2 and then a step up in H2/21, assuming a relatively stable economic re-opening and consumer recovery,” but remains cautious on the idea that we will get full back to normal as headwinds continue to persist. Casey adds, “We continue to be encouraged by the recovery in the U.S., but we believe the new sustainable level will be at one below pre-COVID levels.”

Below you can see BMO’s updated forecasts for 2021 and 2022.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Japan Gold Intersects Gold Mineralization Drilling At Mizobe, Encounters Banded Chalcedony Vein

Antimony Resources Drills 5.10% Sb Over 4.0 Metres At Bald Hill

Related News

CloudMD Gets Price Target Cut By Canaccord Genuity

On Monday CloudMD Software & Services Inc. (TSXV: DOC) reported its fourth quarter results for...

Wednesday, May 4, 2022, 03:06:00 PM

Aphria: The Analyst Take On Q3 Results

On April 12th, Aphria Inc (TSX: APHA) (NASDAQ: APHA) released its fiscal third quarter results....

Wednesday, April 14, 2021, 04:04:00 PM

Peloton: BMO Remains As The Bear Following Q4 Results

At the tail end of August, Peloton Interactive (NASDAQ: PTON) reported its fiscal fourth quarter...

Saturday, September 4, 2021, 01:10:00 PM

Canopy Growth: Canaccord Lowers Price Target After “Uninspiring Quarter”

Last week, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their first fiscal quarter of...

Thursday, August 12, 2021, 10:54:00 AM

GoGold: BMO Lowers Target Price After Production Miss

On January 5th, GoGold Resources Inc. (TSX: GGD) announced its production data for the fiscal...

Friday, January 7, 2022, 02:49:00 PM